Proxima Therapeutics` GliaSite(R) Radiation Therapy System for Brain Tumors Receives Certificate for Inclusion in U.S. NRC Sealed Source and Device Registry
Proxima Therapeutics, Inc., a privately held developer and maker of accelerated cancer treatments using internal radiation therapy, announced today that the State of Georgia Department of Natural Resources has issued a sealed source and device registration certificate for the company`s GliaSite RTS internal radiation treatment for brain tumors.
Sep 18 8:31 AM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010918/hstu013_1.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines